Ola Blennow

3.6k total citations
26 papers, 628 citations indexed

About

Ola Blennow is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Ola Blennow has authored 26 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 15 papers in Epidemiology and 9 papers in Oncology. Recurrent topics in Ola Blennow's work include Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (8 papers) and Neutropenia and Cancer Infections (6 papers). Ola Blennow is often cited by papers focused on Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (8 papers) and Neutropenia and Cancer Infections (6 papers). Ola Blennow collaborates with scholars based in Sweden, Spain and Norway. Ola Blennow's co-authors include Per Ljungman, Jonas Mattsson, Mats Remberger, Olle Ringdén, E. Sparrelid, Jacek Winiarski, Mats Remberger, Mikael Sundin, Markus Maeurer and Michael Uhlin and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Ola Blennow

26 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ola Blennow Sweden 13 268 252 194 127 84 26 628
Jessica Lewis United States 11 169 0.6× 172 0.7× 137 0.7× 37 0.3× 217 2.6× 22 602
Fahir Özkalemkaş Türkiye 14 167 0.6× 128 0.5× 113 0.6× 189 1.5× 42 0.5× 67 634
Riva Fineman Israel 11 165 0.6× 99 0.4× 151 0.8× 67 0.5× 125 1.5× 30 501
Vildan Özkocaman Türkiye 14 175 0.7× 108 0.4× 93 0.5× 186 1.5× 49 0.6× 56 601
Noam Benyamini Israel 17 451 1.7× 144 0.6× 289 1.5× 310 2.4× 118 1.4× 53 963
Anne Thiebaut‐Bertrand France 16 241 0.9× 273 1.1× 326 1.7× 123 1.0× 130 1.5× 29 717
Misato Kikuchi Japan 15 270 1.0× 209 0.8× 66 0.3× 359 2.8× 39 0.5× 64 743
Aki Tanihara Japan 15 205 0.8× 176 0.7× 49 0.3× 247 1.9× 32 0.4× 57 516
Alejandro Restrepo United States 11 219 0.8× 255 1.0× 236 1.2× 286 2.3× 26 0.3× 38 711
Andrea Mengarelli Italy 19 279 1.0× 161 0.6× 164 0.8× 434 3.4× 79 0.9× 64 1.0k

Countries citing papers authored by Ola Blennow

Since Specialization
Citations

This map shows the geographic impact of Ola Blennow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola Blennow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola Blennow more than expected).

Fields of papers citing papers by Ola Blennow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ola Blennow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola Blennow. The network helps show where Ola Blennow may publish in the future.

Co-authorship network of co-authors of Ola Blennow

This figure shows the co-authorship network connecting the top 25 collaborators of Ola Blennow. A scholar is included among the top collaborators of Ola Blennow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ola Blennow. Ola Blennow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pagano, Livio, Georg Maschmeyer, Frédéric Lamoth, et al.. (2025). Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL). Leukemia. 39(7). 1547–1557. 6 indexed citations
2.
Blennow, Ola, et al.. (2023). Successful Combination Treatment for Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Clinical Infectious Diseases. 76(10). 1864–1865. 23 indexed citations
3.
Müller, Thomas, Takuya Sekine, Julia Niessl, et al.. (2023). Anamnestic expansion of Omicron-reactive CD8+ T cells after booster SARS-CoV-2 mRNA vaccination across different immunocompromised states. The Journal of Immunology. 210(Supplement_1). 75.16–75.16. 1 indexed citations
4.
Ray, Shilpa, Jan Vesterbacka, Ola Blennow, et al.. (2023). Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV. npj Biofilms and Microbiomes. 9(1). 104–104. 9 indexed citations
5.
Schain, Frida, Stefano Fedeli, Mats Remberger, et al.. (2023). Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden. Transfusion and Apheresis Science. 62(3). 103705–103705. 2 indexed citations
6.
Blennow, Ola, et al.. (2022). Treatment of COVID-19 with monoclonal antibodies casirivimab and imdevimab in pregnancy. Infection. 51(1). 261–263. 8 indexed citations
7.
Ullberg, Måns, Markus Castegren, Johan Petersson, et al.. (2022). Combining T2Bacteria and T2Candida Panels for Diagnosing Intra-Abdominal Infections: A Prospective Multicenter Study. Journal of Fungi. 8(8). 832–832. 1 indexed citations
8.
Hammarström, Helena, Vanda Friman, Anita Hällgren, et al.. (2022). Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies. Clinical Infectious Diseases. 76(3). e1252–e1260. 10 indexed citations
9.
Ullberg, Måns, Markus Castegren, Johan Petersson, et al.. (2022). T2Candida Assay in the Diagnosis of Intraabdominal Candidiasis: A Prospective Multicenter Study. Journal of Fungi. 8(1). 86–86. 12 indexed citations
10.
11.
Cornely, Oliver A., Danila Seidel, Dorothee Arenz, et al.. (2019). PS1283 CLINICAL IMPLICATIONS OF AZOLE-RESISTANT VERSUS AZOLE-SUSCEPTIBLE INVASIVE ASPERGILLOSIS IN HEMATOLOGICAL MALIGNANCY (CLARITY) – A MULTICENTER STUDY. HemaSphere. 3(S1). 587–587. 1 indexed citations
12.
Maertens, Johan, Ola Blennow, Rafael F. Duarte, & Patricia Muñóz. (2016). The current management landscape: aspergillosis: Table 1.. Journal of Antimicrobial Chemotherapy. 71(suppl 2). ii23–ii29. 22 indexed citations
13.
Blennow, Ola, Mats Remberger, Johan Törlén, et al.. (2016). Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(9). 1684–1689. 12 indexed citations
14.
Bahr, Lena von, Ola Blennow, Jessica J. Alm, et al.. (2015). Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation. Bone Marrow Transplantation. 50(9). 1217–1223. 50 indexed citations
15.
Blennow, Ola, Gustav Fjaertoft, Jacek Winiarski, et al.. (2014). Varicella-Zoster Reactivation after Allogeneic Stem Cell Transplantation without Routine Prophylaxis—The Incidence Remains High. Biology of Blood and Marrow Transplantation. 20(10). 1646–1649. 27 indexed citations
16.
Uhlin, Michael, Mikael Sundin, Ola Blennow, et al.. (2013). Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation. Haematologica. 99(2). 346–352. 124 indexed citations
17.
Blennow, Ola, et al.. (2012). Duration of treatment for candidemia and risk for late-onset ocular candidiasis. Infection. 41(1). 129–134. 18 indexed citations
18.
Blennow, Ola, Katarina LeBlanc, Olle Ringdén, et al.. (2012). Treatment with mesenchymal stromal cells is a risk factor for pneumonia‐related death after allogeneic hematopoietic stem cell transplantation. European Journal Of Haematology. 89(3). 220–227. 63 indexed citations
19.
Blennow, Ola, Katarina Westling, Inga Fröding, & Volkan Özenci. (2011). Pneumonia and Bacteremia Due to Kytococcus schroeteri. Journal of Clinical Microbiology. 50(2). 522–524. 15 indexed citations
20.
Blennow, Ola, Mats Remberger, Lena Klingspor, et al.. (2010). Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT. Bone Marrow Transplantation. 45(12). 1710–1718. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessica Lewis Breakdown of academic impact, for papers by Fahir Özkalemkaş Breakdown of academic impact, for papers by Riva Fineman Breakdown of academic impact, for papers by Vildan Özkocaman Breakdown of academic impact, for papers by Noam Benyamini Breakdown of academic impact, for papers by Anne Thiebaut‐Bertrand Breakdown of academic impact, for papers by Misato Kikuchi Breakdown of academic impact, for papers by Aki Tanihara Breakdown of academic impact, for papers by Alejandro Restrepo Breakdown of academic impact, for papers by Andrea Mengarelli
Rankless by CCL
2026